NM_001366521.1:c.1130-60G>T
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_001366521.1(ATP2B1):c.1130-60G>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0531 in 1,359,474 control chromosomes in the GnomAD database, including 2,313 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.045 ( 253 hom., cov: 32)
Exomes 𝑓: 0.054 ( 2060 hom. )
Consequence
ATP2B1
NM_001366521.1 intron
NM_001366521.1 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.151
Publications
4 publications found
Genes affected
ATP2B1 (HGNC:814): (ATPase plasma membrane Ca2+ transporting 1) The protein encoded by this gene belongs to the family of P-type primary ion transport ATPases characterized by the formation of an aspartyl phosphate intermediate during the reaction cycle. These enzymes remove bivalent calcium ions from eukaryotic cells against very large concentration gradients and play a critical role in intracellular calcium homeostasis. The mammalian plasma membrane calcium ATPase isoforms are encoded by at least four separate genes and the diversity of these enzymes is further increased by alternative splicing of transcripts. The expression of different isoforms and splice variants is regulated in a developmental, tissue- and cell type-specific manner, suggesting that these pumps are functionally adapted to the physiological needs of particular cells and tissues. This gene encodes the plasma membrane calcium ATPase isoform 1. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Jul 2008]
ATP2B1 Gene-Disease associations (from GenCC):
- intellectual developmental disorder, autosomal dominant 66Inheritance: AR, AD Classification: STRONG, MODERATE, LIMITED Submitted by: Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.0875 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ATP2B1 | NM_001366521.1 | c.1130-60G>T | intron_variant | Intron 8 of 20 | ENST00000428670.8 | NP_001353450.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ATP2B1 | ENST00000428670.8 | c.1130-60G>T | intron_variant | Intron 8 of 20 | 5 | NM_001366521.1 | ENSP00000392043.3 | |||
ATP2B1 | ENST00000359142.8 | c.1130-60G>T | intron_variant | Intron 8 of 21 | 5 | ENSP00000352054.3 | ||||
ATP2B1 | ENST00000551310.2 | c.1130-60G>T | intron_variant | Intron 8 of 21 | 3 | ENSP00000447041.2 | ||||
ATP2B1 | ENST00000705822.1 | c.1130-60G>T | intron_variant | Intron 8 of 21 | ENSP00000516172.1 |
Frequencies
GnomAD3 genomes AF: 0.0454 AC: 6906AN: 152100Hom.: 250 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
6906
AN:
152100
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.0541 AC: 65259AN: 1207256Hom.: 2060 AF XY: 0.0535 AC XY: 32377AN XY: 605008 show subpopulations
GnomAD4 exome
AF:
AC:
65259
AN:
1207256
Hom.:
AF XY:
AC XY:
32377
AN XY:
605008
show subpopulations
African (AFR)
AF:
AC:
211
AN:
26850
American (AMR)
AF:
AC:
2443
AN:
35016
Ashkenazi Jewish (ASJ)
AF:
AC:
89
AN:
21822
East Asian (EAS)
AF:
AC:
3711
AN:
36936
South Asian (SAS)
AF:
AC:
3384
AN:
70382
European-Finnish (FIN)
AF:
AC:
4780
AN:
47570
Middle Eastern (MID)
AF:
AC:
44
AN:
3794
European-Non Finnish (NFE)
AF:
AC:
48160
AN:
913588
Other (OTH)
AF:
AC:
2437
AN:
51298
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.509
Heterozygous variant carriers
0
3008
6016
9024
12032
15040
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
1724
3448
5172
6896
8620
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0454 AC: 6916AN: 152218Hom.: 253 Cov.: 32 AF XY: 0.0483 AC XY: 3592AN XY: 74424 show subpopulations
GnomAD4 genome
AF:
AC:
6916
AN:
152218
Hom.:
Cov.:
32
AF XY:
AC XY:
3592
AN XY:
74424
show subpopulations
African (AFR)
AF:
AC:
457
AN:
41544
American (AMR)
AF:
AC:
828
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
AC:
20
AN:
3472
East Asian (EAS)
AF:
AC:
489
AN:
5180
South Asian (SAS)
AF:
AC:
257
AN:
4826
European-Finnish (FIN)
AF:
AC:
1187
AN:
10580
Middle Eastern (MID)
AF:
AC:
3
AN:
294
European-Non Finnish (NFE)
AF:
AC:
3585
AN:
68000
Other (OTH)
AF:
AC:
76
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
337
674
1011
1348
1685
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
84
168
252
336
420
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
234
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.